BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10193209)

  • 21. Quality control of Harpagophytum procumbens and its related phytopharmaceutical products by means of NIR-FT-Raman spectroscopy.
    Baranska M; Schulz H; Siuda R; Strehle MA; Rösch P; Popp J; Joubert E; Manley M
    Biopolymers; 2005 Jan; 77(1):1-8. PubMed ID: 15558669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harpagoside Content in Devil's Claw Extracts.
    Kondamudi N; Turner MW; McDougal OM
    Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
    Anauate MC; Torres LM; de Mello SB
    Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicochemical properties of harpagoside and its in vitro release from Harpagophytum procumbens extract tablets.
    Chrubasik S; Sporer F; Dillmann-Marschner R; Friedmann A; Wink M
    Phytomedicine; 2000 Jan; 6(6):469-73. PubMed ID: 10715851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of swertiamarin from Swertia japonica by human intestinal bacteria.
    el-Sedawy AI; Shu YZ; Hattori M; Kobashi K; Namba T
    Planta Med; 1989 Apr; 55(2):147-50. PubMed ID: 2748732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of β-glucosidase hydrolyzed products of harpagide and harpagoside on cyclooxygenase-2 (COX-2) in vitro.
    Zhang L; Feng L; Jia Q; Xu J; Wang R; Wang Z; Wu Y; Li Y
    Bioorg Med Chem; 2011 Aug; 19(16):4882-6. PubMed ID: 21775152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective Effects Induced by Microwave-Assisted Aqueous Harpagophytum Extract on Rat Cortex Synaptosomes Challenged with Amyloid β-Peptide.
    Ferrante C; Recinella L; Locatelli M; Guglielmi P; Secci D; Leporini L; Chiavaroli A; Leone S; Martinotti S; Brunetti L; Vacca M; Menghini L; Orlando G
    Phytother Res; 2017 Aug; 31(8):1257-1264. PubMed ID: 28635142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isolation and identification of endophytic fungi producing harpagoside and harpagide from Scrophularia ningpoensis].
    Shen ZY; Zhu B; Zhang QL; Qin LP
    Zhongguo Zhong Yao Za Zhi; 2019 May; 44(10):2046-2050. PubMed ID: 31355559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between HPLC and HPTLC-densitometry for the determination of harpagoside from Harpagophytum procumbens CO(2)-extracts.
    Günther M; Schmidt PC
    J Pharm Biomed Anal; 2005 Apr; 37(4):817-21. PubMed ID: 15797807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of solid-phase extraction for the liquid chromatography-mass spectrometry analysis of harpagoside, 8-para-coumaroyl harpagide, and harpagide in equine plasma and urine.
    Colas C; Garcia P; Popot MA; Bonnaire Y; Bouchonnet S
    J Chromatogr Sci; 2008 Feb; 46(2):174-83. PubMed ID: 18366880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new iridoid glycoside from Scrophularia ningpoensis.
    Niu ZR; Wang RF; Shang MY; Cai SQ
    Nat Prod Res; 2009; 23(13):1181-8. PubMed ID: 19731136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Fight against Infection and Pain: Devil's Claw (
    Gxaba N; Manganyi MC
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
    [No Abstract]   [Full Text] [Related]  

  • 33. Iridoid glycosides and polyphenolic compounds from Teucrium chamaedrys L.
    Frezza C; Venditti A; Matrone G; Serafini I; Foddai S; Bianco A; Serafini M
    Nat Prod Res; 2018 Jul; 32(13):1583-1589. PubMed ID: 29058476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of harpagoside in horses after intragastric administration of a Devil's claw (Harpagophytum procumbens) extract.
    Axmann S; Hummel K; Nöbauer K; Razzazi-Fazeli E; Zitterl-Eglseer K
    J Vet Pharmacol Ther; 2019 Jan; 42(1):37-44. PubMed ID: 30242850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harpagoside: from Kalahari Desert to pharmacy shelf.
    Georgiev MI; Ivanovska N; Alipieva K; Dimitrova P; Verpoorte R
    Phytochemistry; 2013 Aug; 92():8-15. PubMed ID: 23642455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iridoid glycoside biosynthesis in Penstemon secundiflorus. Another H-5, H-9 trans-iridoid glycoside.
    Krull RE; Stermitz FR; Franzyk H; Jensen SR
    Phytochemistry; 1998 Nov; 49(6):1605-8. PubMed ID: 9862136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyridine monoterpene alkaloid formation from iridoid glycosides. A novel PMTA dimer from geniposide.
    Frederiksen SM; Stermitz FR
    J Nat Prod; 1996 Jan; 59(1):41-6. PubMed ID: 8984152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stability of iridoids of Harpagophytum procumbens DC. during the preparation of powders and atomized drugs].
    Pourrat H; Texier O; Vennat B; Pourrat A; Gaillard J
    Ann Pharm Fr; 1985; 43(6):601-6. PubMed ID: 3838036
    [No Abstract]   [Full Text] [Related]  

  • 39. Iridoid and aromatic glycosides from Scrophularia ningpoensis Hemsl. and their inhibition of [Ca2+](i) increase induced by KCl.
    Chen B; Liu Y; Liu HW; Wang NL; Yang BF; Yao XS
    Chem Biodivers; 2008 Sep; 5(9):1723-35. PubMed ID: 18816525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review.
    Gagnier JJ; Chrubasik S; Manheimer E
    BMC Complement Altern Med; 2004 Sep; 4():13. PubMed ID: 15369596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.